Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
BLONDER TONGUE LABORATORIES INC (BDR) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/02/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
04/28/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/17/2023 10-K Annual Report for the period ended December 31, 2022
03/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "BLONDER TONGUE ANNOUNCES DEATH OF SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER ERIC SKOLNIK Old Bridge, N.J. – February 23, 2023 – It is with great sadness that Blonder Tongue Laboratories, Inc. Board of Directors announce the death of Senior Vice President and Chief Financial Officer, Eric S. Skolnik. He was 58. “Eric was a most trusted friend and business colleague,” says Bob Palle, incoming CEO of Blonder Tongue. “Eric cared for each and every person that makes up the Blonder Tongue family. Eric’ s tireless work ethic and caring nature would lighten your workload and brighten your outlook following any interaction with him. We loved Eric. Our hearts are with his family at this difficult time. May he rest in peace.” Eric joined Blonder Tongue as the Corporate Controller starting in ..."
02/13/2023 8-K Quarterly results
01/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Blonder Tongue Announces Departure of CEO Reappoints Robert J Palle to Chief Executive Officer and President OLD BRIDGE, New Jersey—January 23, 2023—Blonder Tongue Laboratories, Inc. announced that Edward R. “Ted” Grauch has resigned as Chief Executive Officer and President effective March 18, 2023. Mr. Grauch has held these roles since January 1, 2020, and will remain in these roles until March 18, 2023. The Company’ s Board of Directors has reappointed Robert J “Bob” Palle to serve as Chief Executive Officer and President of the Company, concurrent with Ted’ s departure. Bob has been a Director of Blonder Tongue Laboratories since September 1993. He served as our President from May 2003 until May 2019, our Chief Executive Officer from May 2015 until December 31, 2019 and our Managing Di..."
01/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Deferred Compensation Agreement, by and between Blonder Tongue Laboratories, Inc. and Edward R. Grauch"
11/04/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/04/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/31/2022 8-K Quarterly results
08/15/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/06/2022 8-K Quarterly results
06/28/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
06/24/2022 8-K Quarterly results
06/15/2022 8-K Quarterly results
06/06/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/31/2022 SD Form SD - Specialized disclosure report:
05/26/2022 8-K Quarterly results
05/23/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/23/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
05/11/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/06/2022 8-K Quarterly results
05/06/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/05/2022 8-K Quarterly results
04/22/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/12/2022 PRE 14A Form PRE 14A - Other preliminary proxy statements:
04/08/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "NINTH AMENDMENT TO LOAN AGREEMENT, DATED APRIL 5, 2022."
03/31/2022 10-K Annual Report for the period ended December 31, 2021
03/31/2022 8-K Quarterly results
Docs: "Blonder Tongue Reports Year End and Fourth Quarter 2021 Results OLD BRIDGE, NJ / March 31, 2022 / Blonder Tongue Laboratories, Inc. announced its sales and results for the fourth quarter and year ended December 31, 2021. Commenting on the Company’ s year end and fourth quarter results, Chief Executive Officer Ted Grauch noted, “Although the Company was able to realize positive net earnings for the full year of 2021, the global semiconductor supply chain bottlenecks and supply uncertainties had a significant negative impact on our fourth quarter financial performance, and a number of those supply chain issues have continued into this year. We have been managing through this challenging environment with a combination of product price increases to compensate for raw material premiums, coupled..."
03/14/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blonder Tongue Announces Review of Strategic Alternatives OLD BRIDGE, NJ / March 14, 2022 / Blonder Tongue Laboratories, Inc. announced today that its Board of Directors has authorized a review of strategic alternatives for the Company aimed at enhancing stockholder value. Emerging Growth Equities, Ltd. has been engaged to serve as the exclusive financial advisor to the Board of Directors. The Company does not intend to make any further statements regarding the process of reviewing strategic alternatives unless and until a definitive agreement has been reached or until the process has otherwise ended, unless required by applicable law. No assurance can be given as to whether, when or on what terms any possible transaction might occur. About Blonder Tongue"
03/04/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy